tiprankstipranks
GenSight Biologics SA (FR:SIGHT)
:SIGHT
France Market

GenSight Biologics SA (SIGHT) Income Statement

Compare
2 Followers

GenSight Biologics SA Income Statement

Last quarter (Q2 2024), GenSight Biologics SA's total revenue was €1.73M, an increase of 27.25% from the same quarter last year. In Q2, GenSight Biologics SA's net income was €-5.85M. See GenSight Biologics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 1.27M€ 2.58M€ 5.28M€ 4.39M€ 700.00K
Gross Profit
€ 3.00M€ 2.58M€ 5.28M€ 4.39M€ 700.00K
Operating Expenses
€ 30.96M€ 30.42M€ 33.40M€ 29.33M€ 31.00M
Depreciation and Amortization
€ 3.03M€ 1.03M€ 928.00K€ 926.00K€ 985.00K
EBITDA
€ -21.73M€ -26.44M€ -26.83M€ -34.13M€ -29.31M
Operating Income
€ -29.70M€ -27.84M€ -28.13M€ -24.93M€ -30.30M
Other Income/Expenses
€ 3.48M€ 215.00K€ -489.00K€ -9.08M€ -566.00K
Pretax Income
€ -26.22M€ -27.62M€ -28.61M€ -34.01M€ -30.71M
Net Income
€ -26.22M€ -27.62M€ -28.62M€ -34.02M€ -30.71M
Per Share Metrics
Basic EPS
€ -0.54€ -0.60€ -0.63€ -0.97€ -1.08
Diluted EPS
€ -0.54€ -0.60€ -0.63€ -0.97€ -1.08
Weighted Average Shares Outstanding
48.32M 46.33M 45.15M 35.13M 28.38M
Weighted Average Shares Outstanding (Diluted)
48.32M 46.33M 45.15M 35.13M 28.38M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis